» Articles » PMID: 35401995

DFT Investigation on the Application of Pure and Doped XN (X = B and Al) Fullerene-like Nano-cages Toward the Adsorption of Temozolomide

Overview
Journal R Soc Open Sci
Specialty Science
Date 2022 Apr 11
PMID 35401995
Authors
Affiliations
Soon will be listed here.
Abstract

The sensitivity of pure and doped XN (X = B and Al) fullerene-like nano-cages (FLNs) toward the anti-cancer drug temozolomide (TMZ) is probed herein at DFT/M06-2X-D3/6-311G(d,p) theoretical level in both gas phase and water. A noticeable affinity of the FLNs toward TMZ was observed along with the negative gas-phase adsorption energies -1.37 and -2.09 eV for the most stable configurations of pure BN and AlN pristines, respectively. Considerable charge transfer from TMZ to the FLNs was also revealed via NBO analysis and the Hirshfeld atomic charges, making the dipole moment vector of the molecular complexes to be oriented from the nano-cages to the TMZ moiety. Furthermore, a percentage decrease in the HOMO-LUMO energy gap (Δ ) of 38.09 and 17.72% was obtained for the BN and AlN nano-cages, respectively. The percentage change in Δ was found to be reduced upon doping and solvation of the FLNs. Finally, a recovery time in vacuum ultraviolet light of 1.06 s is found for the complex with pure BN, which in addition to the above-mentioned parameters make this boron nitride cage the best sensor for TMZ, among the FLNs considered in the present work.

Citing Articles

A Comparative DFT Investigation of the Adsorption of Temozolomide Anticancer Drug over Beryllium Oxide and Boron Nitride Nanocarriers.

Ibrahim M, Rady A, Sidhom P, Sayed S, Ibrahim K, Awad A ACS Omega. 2024; 9(23):25203-25214.

PMID: 38882172 PMC: 11170632. DOI: 10.1021/acsomega.4c02882.


Elucidating anticancer drugs release from UiO-66 as a carrier through the computational approaches.

Boroushaki T, Ganjali Koli M, Malekshah R, Dekamin M RSC Adv. 2023; 13(45):31897-31907.

PMID: 37920197 PMC: 10618728. DOI: 10.1039/d3ra05587f.


DFT investigation of temozolomide drug delivery by pure and boron doped C fullerene-like nanocages.

Tamafo Fouegue A, de Paul Zoua V, Kounou G, Ndjopme Wandji B, Ghogomu J, Ntieche R Nanoscale Adv. 2023; 5(21):5880-5891.

PMID: 37881702 PMC: 10597570. DOI: 10.1039/d3na00402c.


Density functional theory computation of the intermolecular interactions of Al@C and Al@MgO semiconducting quantum dots conjugated with the glycine tripeptide.

Mohammadi H, Azami S, Rafii-Tabar H RSC Adv. 2023; 13(15):9824-9837.

PMID: 36998517 PMC: 10043880. DOI: 10.1039/d3ra01154b.


DFT investigation on the application of pure and doped XN (X = B and Al) fullerene-like nano-cages toward the adsorption of temozolomide.

Ndjopme Wandji B, Tamafo Fouegue A, Nkungli N, Ntieche R, Wahabou A R Soc Open Sci. 2022; 9(4):211650.

PMID: 35401995 PMC: 8992703. DOI: 10.1098/rsos.211650.

References
1.
Zhao Y, Schultz N, Truhlar D . Design of Density Functionals by Combining the Method of Constraint Satisfaction with Parametrization for Thermochemistry, Thermochemical Kinetics, and Noncovalent Interactions. J Chem Theory Comput. 2015; 2(2):364-82. DOI: 10.1021/ct0502763. View

2.
Abdolahi N, Aghaei M, Soltani A, Azmoodeh Z, Balakheyli H, Heidari F . Adsorption of Celecoxib on BN fullerene: Spectroscopic and DFT/TD-DFT study. Spectrochim Acta A Mol Biomol Spectrosc. 2018; 204:348-353. DOI: 10.1016/j.saa.2018.06.077. View

3.
Al-Otaibi J, Sheena Mary Y, Mary Y, Kaya S, Serdaroglu G . DFT computational study of trihalogenated aniline derivative's adsorption onto graphene/fullerene/fullerene-like nanocages, XY (X = Al, B, and Y = N, P). J Biomol Struct Dyn. 2021; 40(19):8630-8643. DOI: 10.1080/07391102.2021.1914172. View

4.
Misra R, Acharya S, Sahoo S . Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today. 2010; 15(19-20):842-50. DOI: 10.1016/j.drudis.2010.08.006. View

5.
de Jesus A, Grossman S, Paun O . Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide. J Neurooncol. 2009; 94(3):445-8. PMC: 3696988. DOI: 10.1007/s11060-009-9882-8. View